Pulmonary Cryptococcal Infection Complicating Gefitinib Therapy in a Patient With EGFR L858R‐Positive Lung Adenocarcinoma: A Case Report
ABSTRACT In patients with EGFR‐mutant lung adenocarcinoma receiving gefitinib or other EGFR‐TKIs, the development of new pulmonary nodules should not be hastily attributed to disease progression; secondary pulmonary cryptococcosis should be considered in the differential diagnosis.
Authors
- Chunyan Wu (ORCID: https://orcid.org/0009-0008-6357-4913)
- G Li
- Qianyu Wang (ORCID: https://orcid.org/0000-0001-7048-8847)
- Ting Jiang
- Yuxiang Zhou
- Jiangrong Liao
- Yun Wang (ORCID: https://orcid.org/0009-0009-0683-2071)
- Fang Yang
Institutions
- Zunyi Medical University (CN)
- Affiliated Hospital of Zunyi Medical College (CN)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1002/ccr3.72684
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00